WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy L. BurroughsChief Executive Officer2026-02-178,159$39.22
$319.96kSell
Amy L. BurroughsChief Executive Officer2026-02-174,083$39.80
$162.50kSell
Amy L. BurroughsChief Executive Officer2026-02-1714,583$4.64
$67.67kBuy
Amy L. BurroughsChief Executive Officer2026-02-172,341$38.07
$89.11kSell
Amy L. BurroughsChief Executive Officer2026-01-1527,083$4.64
$125.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-1514,583$4.64
$67.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-1561,228$37.02
$2.27MSell
Amy L. BurroughsChief Executive Officer2026-01-157,521$37.53
$282.23kSell
Amy L. BurroughsChief Executive Officer2026-01-1527,083$4.64
$125.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-0571,339$38.10
$2.72MSell

1 of 3

TERN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC12.81%11,536,701$536.69MInsider
Blackrock Inc9.10%8,194,218$381.20MInstitution
Morgan Stanley8.82%7,945,608$369.63MInstitution
Adage Capital Partners GP LLC6.16%5,550,000$258.19MInstitution
Vanguard Group Inc6.13%5,523,948$256.97MInstitution
Vivo Capital LLC5.94%5,346,928$248.74MInstitution
Vestal Point Capital LP5.00%4,500,000$209.34MInstitution
Janus Henderson Group PLC3.75%3,379,569$157.22MInstitution
Citadel Advisors LLC3.52%3,166,642$147.31MInstitution
Capitolis Liquid Global Markets LLC3.38%3,045,200$141.66MInstitution

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN85.40%14.60%Net SellingNet Selling
ERAS70.55%27.68%Net BuyingNet Buying
VKTX62.25%8.90%Net SellingNet Selling
LGND18.32%81.68%Net SellingNet Selling
CRNX89.53%10.47%Net BuyingNet Buying
View Top Biotech Stocks

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 134.54% institutional shareholders, 23.00% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.54M shares representing 12.81% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $536.69M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.